For research use only. Not for therapeutic Use.
Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD)[1][2].
Salbutamol (16 μM, 24 h) significantly induces EMT, migration and invasion by ERK (extracellular signal-regulated kinase) phosphorylation in gastric cancer cells[1].
Salbutamol (5 mg/kg/day, orally, for 2 consecutive weeks) can increase tumor growth in nude mice with gastric cance[1].
Salbutamol (6 mg/kg orally for 4 weeks) has a significant protective effect against STZ (HY-13753)-induced skeletal muscle atrophy in diabetic rats[2].
Catalog Number | I002395 |
CAS Number | 18559-94-9 |
Synonyms | 4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol |
Molecular Formula | C13H21NO3 |
Purity | ≥95% |
InChI | InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3 |
InChIKey | NDAUXUAQIAJITI-UHFFFAOYSA-N |
SMILES | CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O |
Reference | [1]. Lu Y, et al. Chronic stress model simulated by salbutamol promotes tumorigenesis of gastric cancer cells through β2-AR/ERK/EMT pathway. J Cancer. 2022 Jan 1;13(2):401-412. [2]. Hong YP, et al. Effects of Castanospermine on Inflammatory Response in a Rat Model of Experimental Severe Acute Pancreatitis. Arch Med Res. 2016 Aug;47(6):436-445. |